Compare FMC Corp (FMC) vs Morgan Stanley (MS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FMC Corp vs Morgan Stanley — how do they compare? FMC Corp trades at $11.45 (market cap $1.36B), while Morgan Stanley trades at $221.19 (market cap $359.28B). The key difference: Morgan Stanley is far larger — about 264.2× FMC Corp's market cap, and FMC Corp pays the higher dividend (2.95%). Which is the better fit depends on your goals.
| FMC | MS | |
|---|---|---|
Market Cap | $1.36B | $359.28B |
Sector | Basic Materials | Financials |
52-Week High | $43.90 | $228.42 |
52-Week Low | $10.72 | $139.09 |
Enterprise Value | $5.50B | — |
Dividend Yield | 2.95% | 1.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $10.72, down 1.74% on the day, reflecting ongoing challenges despite recent strategic moves. The stock shows a bearish technical trend with oversold RSI signals, while fundamentals reveal significant pressure with a net income margin of -72.93% and negative ROE of -80.78% for 2025. Recent developments include a $400 million minority investment from Tessenderlo Group and regulatory submission for new herbicide rimisoxafen, providing some operational support amid financial restructuring.
The outlook remains cautious with analyst consensus leaning neutral (50% Hold) despite a $16 price target suggesting 49% upside. Key risks include persistent revenue declines, high debt levels, and negative cash flow from operations. Investment opportunity exists if new product approvals and debt reduction efforts successfully stabilize profitability, but current financial metrics indicate substantial execution risk near term.
Morgan Stanley (MS) trades at $228.17, up 3.2% with strong technical and fundamental momentum. The stock shows bullish technical signals with consistent earnings beats and robust revenue growth from $57.6B in 2024 to $66.0B in 2025. Recent news highlights the firm's role in leading Anthropic's IPO and expanding AI integration in wealth management, reinforcing its market position.
Outlook remains positive with analyst consensus at Buy (53.85%) and $229 price target. Key opportunities include sustained earnings growth and strategic initiatives, while risks involve volatile cash flows and high debt levels. The stock presents a balanced risk-reward profile for investors seeking financial sector exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →About Morgan Stanley
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments. The company had about $5 trillion of client assets as well as over 70,000 employees at the end of 2021. Approximately 50% of the company's net revenue is from its institutional securities business, with the remainder coming from wealth and investment management. The company derives about 30% of its total revenue outside the Americas.
Read more on MS →
